The growth hormone receptor polymorphism in patients with acromegaly: Relationship to BMI and glucose metabolism

Pituitary

Volumn 15, Issue 3, 2012, Pages 374-379

  Turgut, Sebahat ^a   Akın, Fulya ^a   Ayada, Ceylan ^a   Topsakal, Şenay ^a   Yerlikaya, Emrah ^a   Turgut, Günfer ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

Acromegaly; BMI; d3GHR polymorphism; IGF I; Insulin

Indexed keywords

GLITAZONE DERIVATIVE; GLUCOSE; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE; TRIACYLGLYCEROL;

ACROMEGALY; ADULT; ALLELE; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENETIC RISK; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INSULIN RESISTANCE; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 84867403193     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-011-0329-9     Document Type: Article

References (29)

1. Parkinson C, Ryder WD, Trainer PJ (2001) The relationship between serum GH and serum IGF-I in acromegaly is genderspecific. J Clin Endocrinol Metab 86:5240-5244
2. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO (1987) Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 64:51-58
3. Barkan AL, Halasz I, Dornfeld KJ, Jaffe CA, Friberg RD, Chandler WF, Sandler HM (1997) Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly. J Clin Endocrinol Metab 82:3187-3191
4. Pantel J, Machinis K, Sobrier ML, Duquesnoy P, Goossens M, Amselem S (2000) Species-specific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution. J Biol Chem 275: 18664-18669
5. Schmid C, Krayenbuehl PA, Bernays RL, Zwimpfer C, Maly FE, Wiesli P (2007) Growth hormone (GH) receptor isoform in acromegaly: lower concentrations of GH but not insulin-like growth factor-1 in patients with a genomic deletion of exon 3 in the GH receptor gene. Clin Chem 53:1484-1488
6. Dos Santos C, Essioux L, Teinturier C, Tauber M, Goffin V, Bougneres P (2004) A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat Genet 36:720-724
7. Binder G, Baur F, Schweizer R, Ranke MB (2006) The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children. J Clin Endocrinol Metab 91: 659-664
8. Jorge AA, Marchisotti FG, Montenegro LR, Carvalho LR, Mendonca BB, Arnhold IJ (2006) Growth hormone (GH) pharmacokinetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency. J Clin Endocrinol Metab 91:1076-1080
9. Mercado M, González B, Sandoval C, Esquenazi Y, Mier F, Vargas G, de los Monteros AL, Sosa E (2008) Clinical and biochemical impact of the d3 (fl) growth hormone receptor genotype in acromegaly. J Clin Endocrinol Metab 93(9):3411-3415
10. Bianchi A, Giustina A, Cimino V, Pola R, Angelini F, Pontecorvi A, De Marinis L (2009) Influence of growth hormone receptor d3 and full-lenght isoforms on biochemical treatment outcomes in acromegaly. J Clin Endocrinol Metab 94(6):2015-2022
11. Holdaway IM, Rajasoorya RC, Gamble GD (2004) Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 89:667-674
12. Montefusco L, Filopanti M, Ronchi CL, Olgiati L, La-Porta C, Losa M, Epaminonda P, Coletti F, Beck-Peccoz P, Spada A, Lania AG, Arosio M (2010) d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype. Clin Endocrinol 72:661-667
13. Kamenicky P, Dos Santos C, Espinosa C, Salenave S, Galland F, Le Bouc Y, Maison P, Bougnères P, Chanson P (2009) D3 GH receptor polymorphism is not associated with IGF1 levels in untreated acromegaly. Eur J Endocrinol 161(2):231-235
14. Freda PU (2003) Current concepts in the biochemical assessment of the patient with acromegaly. Growth Horm IGF Res 13: 171-184
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
16. Lebovitz HE (2002) Insulin resistance and the insulin resistance syndrome. In: Clinician's manual on insulin resistance. Science Press, London, pp 1-15
17. Audi L, Esteban C, Carrascosa A, Espadero R, Perez-Arroyo A, Arjona R, Clemente M, Wollmann H, Fryklund L, Parodi LA (2006) Exon 3-deleted/full-length growth hormone receptor polymorphism genotype frequencies in Spanish short small-forgestational-age (SGA) children and adolescents (n = 247) and in an adult control population (n = 289) show increased fl/fl in short SGA. J Clin Endocrinol Metab 91:5038-5043
18. Qiu XS, Tang NL, Yeung HY, Qiu Y, Cheng JC (2007) Genetic association study of growth hormone receptor and idiopathic scoliosis. Clin Orthop Relat Res 462:53-58
19. Ko JM, Park JY, Yoo HW (2009) Common exon 3 polymorphism of the GH receptor (GHR) gene and effect of GH therapy on growth in Korean children with idiopathic short stature (ISS). Clin Endocrinol 70(1):82-87
20. Strawbridge RJ, Karvestedt L, Li C, Efendic S, Ostenson CG, Gu HF, Brismar K (2007) GHR exon polymorphism: association type 2 diabetes mellitus and metabolic disorder. Growth Horm IGF Res 17:392-398
21. Kenth G, Shao Z, Cole DE, Goodyer CG (2007) Relationship of the human growth hormone receptor exon 3 genotype with final adult height and bone mineral density. J Clin Endocrinol Metab 92:725-728
22. Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102-152
23. Bondanelli M, Ambrosio MR, Uberti EC (2001) Pathogenesis and prevalence of hypertension in acromegaly. Pituitary 4: 239-249
24. Moller J (2003) Effects of growth hormone on fluid homeostasis. Clinical and experimental aspects. Growth Horm IGF Res 13: 55-74
25. Feld S, Hirschberg R (1996) Growth hormone, the insulin-like growth factor system, and the kidney. Endocr Rev 17:423-480
26. Ranke MB, Partsch CJ, Lindberg A, Dorr HG, Bettendorf M, Hauffa BP, Schwarz HP, Mehls O, Sander S, Stahnke N, Steinkamp H, Said E, Sippell W (2002) Adult height after GH therapy in 188 Ullrich-Turner syndrome patients: results of the German IGLU Follow-up Study 2001. Eur J Endocrinol 147: 625-633
27. Binder G, Trebar B, Baur F, Schweizer R, Ranke MB (2008) Homozygosity of the d3-growth hormone receptor polymorphism is associated with a high total effect of GH on growth and a low BMI in girls with Turner syndrome. Clin Endocrinol 68:567-572
28. Ko JM, Kim JM, Cheon CK, Kim DH, Lee DY, Cheong WY, Kim EY, Park MJ, Yoo HW (2010) The common exon 3 polymorphism of the growth hormone receptor gene and the effect of growth hormone therapy on growth in Korean patients with Turner syndrome. Clin Endocrinol 72(2):196-202
29. Jensen RB, Vielwerth S, Larsen T, Greisen G, Leffers H, Juul A (2007) The presence of the d3-growth hormone receptor polymorphism is negatively associated with fetal growth but positively associated with postnatal growth in healthy subjects. J Clin Endocrinol Metab 92:2758-2763